Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving...

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• The tumor suppressor p53 is crucial for regulating cell growth and apoptosis by transactivating target genes.
• Understanding p53's regulatory network is vital for developing effective cancer therapies.

Purpose of the Study:

• To identify novel p53 target genes involved in cancer progression.
• To elucidate the role of PHLDB3 in p53-mediated tumor suppression.
• To evaluate PHLDB3 as a potential therapeutic target in human cancers.

Main Methods:

• Gene expression analysis to identify p53 targets.
• Cell-based assays to assess PHLDB3's effect on proliferation and apoptosis.
• Western blotting and co-immunoprecipitation to study protein interactions (PHLDB3, MDM2, p53).
• In vivo mouse xenograft models to evaluate tumor growth inhibition.
• Analysis of The Cancer Genome Atlas (TCGA) and other cancer genomic databases.

Main Results:

• PHLDB3 was identified as a direct p53 target gene.
• PHLDB3 overexpression enhanced cancer cell proliferation and inhibited apoptosis in wild-type p53 cells.
• PHLDB3 binds to MDM2, promoting p53 ubiquitination and degradation.
• PHLDB3 knockdown significantly inhibited tumor growth in p53-wild-type xenografts and sensitized cells to chemotherapy.
• PHLDB3 amplification and/or high expression were observed in numerous human cancers.

Conclusions:

• PHLDB3 promotes tumor growth by negatively regulating p53 stability and function.
• PHLDB3 acts in a negative feedback loop to inactivate p53.
• PHLDB3 represents a promising therapeutic target for various human cancers, particularly those with wild-type p53.